NCT06331910View on ClinicalTrials.gov

Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

May 1, 2025

Conditions

Neurotrophic Keratopathy

Interventions

DRUG

insulin eye drops

Insulin eye drops deliver insulin directly to the cornea, They exploit insulin's ability to stimulate cell growth, potentially reducing healing time with minimal side effects.

All Listed Sponsors

lead

Assiut University

OTHER

NCT06331910 - Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers | Biotech Hunter | Biotech Hunter